Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Baxter
US Department of Justice
Chubb
UBS

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 6,492,512

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,492,512
Title: Method and reagent for treatment of lung cancer and other malignancies caused by the deregulation of L-MYC gene expression
Abstract:An enzymatic RNA molecule which cleaves mRNA associated with development or maintenance of lung cancer.
Inventor(s): Thompson; James D. (Boulder, CO), Draper; Kenneth G. (Boulder, CO)
Assignee: Ribozyme Pharmaceuticals, Inc. (Boulder, CO)
Application Number:07/936,532
Patent Claims:see list of patent claims

Details for Patent 6,492,512

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2037-11-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2037-11-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2037-11-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Deloitte
Citi
Cipla
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.